Significant association of longer forms of CCTTT Microsatellite repeat in the inducible nitric oxide synthase promoter with severe malaria in Thailand.

A CCTTT microsatellite repeat in the inducible nitric oxide synthase (iNOS) promoter was analyzed among 256 adult patients with severe Plasmodium falciparum malaria and 179 adult patients with mild malaria living in northwestern Thailand. Genotypes with longer forms of the CCTTT repeat (alleles of > or =15 repeats) were significantly associated with severe malaria (odds ratio [OR], 2.14; P=.0029, chi(2) test). More interestingly, the summed repeat number of both microsatellite alleles in an individual was found to be a significant risk factor for severe malaria (OR, 1.11; logistic regression analysis, P=.0041). The single nucleotide substitution, -954G-->C, in the iNOS promoter was rare in Thai patients with malaria. No variations were detected in the iNOS promoter region containing functional NF-kappaB elements at -5.2, -5.5, -5.8, and -6.1 kb upstream of the iNOS transcriptional start site. Thus, a CCTTT repeat in the iNOS promoter may play a key role in the pathogenesis of severe malaria.

[1]  I. Charles,et al.  Inducible nitric oxide synthase polymorphism and fatal cerebral malaria , 1998, The Lancet.

[2]  I. Clark,et al.  Proposed link between cytokines, nitric oxide and human cerebral malaria. , 1991, Parasitology today.

[3]  M. Alpers,et al.  Nitric oxide synthase 2(Lambaréné) (G-954C), increased nitric oxide production, and protection against malaria. , 2001, The Journal of infectious diseases.

[4]  D. Kwiatkowski,et al.  Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. , 1994, Nature.

[5]  B. Lell,et al.  Polymorphism in promoter region of inducible nitric oxide synthase gene and protection against malaria , 1998, The Lancet.

[6]  I. Charles,et al.  Evolution of a homopurine-homopyrimidine pentanucleotide repeat sequence upstream of the human inducible nitric oxide synthase gene. , 1997, Gene.

[7]  N. Anstey,et al.  Nitric oxide in Tanzanian children with malaria: inverse relationship between malaria severity and nitric oxide production/nitric oxide synthase type 2 expression , 1996, The Journal of experimental medicine.

[8]  N. Anstey,et al.  Nitric oxide synthase type 2 promoter polymorphisms, nitric oxide production, and disease severity in Tanzanian children with malaria. , 1999, The Journal of infectious diseases.

[9]  S. Hoffman,et al.  IFN-gamma inhibits development of Plasmodium berghei exoerythrocytic stages in hepatocytes by an L-arginine-dependent effector mechanism. , 1991, Journal of immunology.

[10]  K. Tokunaga,et al.  Lack of association of -308A/G TNFA promoter and 196R/M TNFR2 polymorphisms with disease severity in Thai adult malaria patients. , 2001, American journal of medical genetics.

[11]  Severe and complicated malaria. World Health Organization, Division of Control of Tropical Diseases. , 1990, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[12]  C. Patterson,et al.  Genotyping and functional analysis of a polymorphic (CCTTT)n repeat of NOS2A in diabetic retinopathy , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[13]  S. Moncada,et al.  The role of TH1 and TH2 cells in a rodent malaria infection. , 1993, Science.

[14]  David A. Geller,et al.  Multiple NF-κB Enhancer Elements Regulate Cytokine Induction of the Human Inducible Nitric Oxide Synthase Gene* , 1998, The Journal of Biological Chemistry.

[15]  R. Udomsangpetch,et al.  Inducible nitric oxide synthase expression is increased in the brain in fatal cerebral malaria , 2000, Histopathology.

[16]  L. Rénia,et al.  L‐Arginine‐dependent destruction of intrahepatic malaria parasites in response to tumor necrosis factor and/or interleukin 6 stimulation , 1991, European journal of immunology.

[17]  D. Kwiatkowski,et al.  Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria , 1994, Nature.